Nature Communications

Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer

2026-02-25

Full text

DOI https://doi.org/10.1038/s41467-026-70001-5